Delivering consistent, high-level and high-quality expression are key performance criteria for Kerry’s range of product solutions targeting upstream optimization of cell media. Monoclonal antibodies, in particular, are highly valued therapeutics that demand exceptional titers and consistent glycosylation profiles. Kerry has a long history of commercial success, with 6 of the top 10 blockbuster biologics utilizing Kerry media solutions. This is an important consideration for biopharma companies developing biosimilars as well.

Formulation Expert

Let the expert help you with your formulation